Full name
NYSKI OŚRODEK ONKOLOGII "ONKOVIT" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
NYSKI OŚRODEK ONKOLOGII "ONKOVIT" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. RODZIEWICZÓWNY 34, 48-300 NYSA
TAX ID8971719347
Rate company:
NYSKI OŚRODEK ONKOLOGII "ONKOVIT" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID8971719347
KRS0000350048
Share capital10,000.00 zł
address
UL. RODZIEWICZÓWNY 34, 48-300 NYSA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
8971719347
REGON
020345315
KRS
0000350048
Legal form
limited liability company
Register Address
UL. RODZIEWICZÓWNY 34, 48-300 NYSA
Date of registration in KRS
2010-03-01
Date of commencement of economic activity
2010-03-01
Act signature
OP.VIII NS-REJ.KRS/10737/22/492/ADE
Pkd codes
86.22.Z - Specialist medical practice
47.74.Z - Retail sale of medical and orthopedic products
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.10.Z - Hospital activities
86.21.Z - General medical practice
86.23.Z - Dental practice
86.90.E - Healthcare
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | 0,4 | 0,3 | 0,2 | -54 |
Gross profit (loss) | 0,5 | 0,1 | 0,4 | 237,2 |
EBITDA | 0,7 | 0,3 | 0,6 | 120,2 |
Short time liabilities | 0,7 | 0,5 | 0,4 | -27 |
Other operating costs | 0 | 1,1 | 0 | -99,2 |
Equity capital | 2,6 | 2,2 | 2,3 | 3,6 |
Operating profit (EBIT) | 0,5 | 0,1 | 0,4 | 273,6 |
Assets | 3,7 | 3 | 2,9 | -3,9 |
Net profit (loss) | 0,5 | 0,1 | 0,4 | 235,4 |
Cash | 0,6 | 1 | 0,8 | -22,2 |
Net income from sale | 2,6 | 3,1 | 3,8 | 21,7 |
Liabilities and provisions for liabilities | 1,1 | 0,8 | 0,6 | -25,5 |
Working assets | 1,3 | 1,5 | 1,3 | -14 |
Other income costs | 0,2 | 0,9 | 0,2 | -76,1 |
Depreciation | 0,2 | 0,2 | 0,2 | 24 |
% | % | % | p.p. | |
Profitability of capital | 18,8 | 4,9 | 16 | 11,1 |
Equity capital to total assets | 71 | 74,3 | 80,1 | 5,8 |
Gross profit margin | 20,6 | 3,9 | 10,8 | 6,9 |
EBITDA Margin | 26,9 | 8,2 | 14,8 | 6,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 100 | 61 | 37 | -24 |
Current financial liquidity indicator | 1.906416416168213 | 2.912846326828003 | 3.4292216300964355 | 0,5 |
Net dept to EBITDA | -0.20707911252975464 | -2.624807596206665 | -0.9504151344299316 | 1,6 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
GABINET OKULISTYCZNY Joanna Karczewska
Nowy Sącz
Deamed Słupsk
SŁUPSK
MHajzyk
Katowice
ADRIAN ANDRZEJCZAK
Lublin